Deterioration Mechanism of EVA-Modified OPC-SAC Pavement Repair Materials under Extremely High Temperatures
Journal of Engineering System · 2026-03 · 4 (1) · 201-207
DOI: 10.62517/jes.202602129 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Engineering System, 2026-03. Verfasst von Jianan Liang und 5 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Rising infrastructure demands push cement-based repair materials to their limits. Hot-patch scenarios subject OPC-SAC blends to wide temperature swings that disturb hydration, destabilise hydrates, and resulting in micro-cracking, reduced toughness, and increased maintenance demands. We prepared EVA-latex modified OPC-SAC, exposed it to 20–80°C, and tracked property evolution. At 23°C, EVA cut flexural/ compressive strength by 25.9%/31.5%. From 23°C to 80°C, compared to the plain blend, the reduction in flexural strength of the modified composite stabilized at high temperatures (after an initial complex variation), while the compressive strength increased 5.79% higher than the control group, demonstrating EVA’s stabilizing effect under extremely high temperatures.
Zitieren
APA
Liang, J., Yao, S., Li, N., Li, N., Yang, Y., & Xu, M. (2026). Deterioration Mechanism of EVA-Modified OPC-SAC Pavement Repair Materials under Extremely High Temperatures. Journal of Engineering System, 4(1), 201-207. https://doi.org/10.62517/jes.202602129
Vancouver
Liang J, Yao S, Li N, Li N, Yang Y, Xu M. Deterioration Mechanism of EVA-Modified OPC-SAC Pavement Repair Materials under Extremely High Temperatures. Journal of Engineering System. 2026;4(1):201-207. doi:10.62517/jes.202602129
BibTeX
@article{Liang2026,
author = {Liang, Jianan and Yao, Shuang and Li, Ni and Li, Nan and Yang, Yuxin and Xu, Mingjia},
title = {Deterioration Mechanism of EVA-Modified OPC-SAC Pavement Repair Materials under Extremely High Temperatures},
journal = {Journal of Engineering System},
year = {2026},
volume = {4},
number = {1},
pages = {201--207},
doi = {10.62517/jes.202602129}
}
EUVIMED